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ABSTRACT
Objective: Reversed-phase chromatography has become the method of choice to separate compounds that are similar in structure to each other. 
Selectivity, resolution and retention time can be improved by controlling different variants. The choice of the mobile phase for the analysis is important 
to achieve the best chromatographic results. The retention time, shape and width of chromatographic peaks are dependent on the buffer pH and also 
on the amount of organic modifier in the mobile phase. The aim of this study is to separate two lincosamide antibiotics-clindamycin phosphate and 
lincomycin hydrochloride using different mobile phases.
Method: Each mobile phase was made up of a phosphate buffer and acetonitrile. The mobile phases had different buffer pHs and different percentage 
compositions of acetonitrile. Analysis was performed using nine different mobile phases to observe which of them gave the best results in terms of 
resolution, retention time, and peak shape.
Results: The best results were given when using a mobile phase having 30% acetonitrile with a buffer pH of 3.0.
Conclusion: This work shows the importance of adjusting the amount of the organic modifier in the mobile phase together with the buffer pH. The 
amount of organic modifier should not be too large as to cause loss of resolution between two neighboring peaks and not too small so as to result in 
too long of a retention time. The pH should be chosen to have the greatest percentage of ionized or unionized species of the analyte of interest present.
Keywords: Reversed-phase chromatography, Clindamycin, Lincomycin, Acetonitrile, pH.
INTRODUCTION
Owing to its versatility, specificity and sensitivity high-performance 
liquid chromatography (HPLC) has become the method of choice for 
separating and analyzing compounds in the pharmaceutical industry. 
Reversed- phase chromatography, which is the most commonly used 
type of liquid chromatography [1] can be used to distinguish between 
and quantify compounds that are structurally very similar to one 
another.
When selecting and establishing the ideal separation conditions, 
various parameters have to be taken into account. In the majority 
of practical scenarios, in method development, a single stationary 
phase is used, and optimization in selectivity, resolution and retention 
time is achieved by changing other variants [2]. Different mobile 
phase characteristics can affect chromatographic results. Among these 
are flow rate, type of buffer used, type of organic modifier used and pH 
of the mobile phase [3-5]. The retention of analyte peaks, as well as 
their shape and width, are all dependent on the pH of and the amount 
of organic modifier in the mobile phase [6]. When changing the mobile 
phase pH both the retention time and selectivity of the analytes of 
interest vary [7]. Ideally, results are favorable for both the retention 
time and selectivity. Shorter retention times result in quicker analyses, 
but retention times that are too short may lead to compromisation, lack 
of selectivity and loss in resolution between two or more neighboring 
peaks.
The work reported in this paper describes the effects of varying pH and 
quantity of organic modifier in the mobile phase when separating a 
mixture of clindamycin phosphate and lincomycin hydrochloride.
Clindamycin phosphate and lincomycin hydrochloride are two 
clinically widely used lincosamide antibiotics [8,9]. Lincomycin (Fig. 1) 
was the first lincosamide antibiotic to be produced after being isolated 
from Streptomyces lincolnensis [10]. The attachment of a chlorine 
group at the carbon-7 position to produce clindamycin increases the 
potency significantly by producing a more lipophilic compound [11]. 
A phosphate group attached to clindamycin produces clindamycin 
phosphate, a pro-drug with greater aqueous solubility and a marked 
decrease of pain upon injection [12,13].
Lincomycin has a pKa value of 7.6 [14] whilst clindamycin phosphate 
has two pKa values: pKa1-0.96 and pKa2-6.081 [15].
The Henderson-Hasslebalch equation:
pH = pKa + log ([A−]/[HA]) for a weak acid and
pH = pKb + log ([RNH2]/[RNH3
+) for a weak base
relates pH with the pKa of a weak acid and with the ratio of the 
concentrations of its protonated (HA) and unprotonated species 
(A−) present and with the pKb of a weak base and the ratio of the 
concentrations of the base and its protonated species. These are all very 
important considerations when using this type of chromatography.
According to the Henderson-Hasslebalch equation, when the pH of 
the mobile phase is <7.6, lincomycin is increasingly more present 
in its protonated form (Fig. 1). At pH values above 7.6, lincomycin is 
increasingly more present in its unprotonated form.
Since clindamycin phosphate has two pKa values, at pH values lower 
than 0.9, all of its oxygen atoms are protonated (Fig. 2). At pH values 
between 0.9 and 6.081 the ratio between the concentration of the 
species with one of the oxygens of its phosphate group protonated 
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and the concentration of the unprotonated species varies (Fig. 3). 
At values above 6.081, the species with all of its oxygens unprotonated 
predominates (Fig. 4).
When dealing with analytes, which can be ionized, control of pH is the 
key to avoid obtaining peaks, which are broad, split or non-symmetrical. 
This is because better peak shapes can be attained when the analyte of 
interest is present in a single form [16].
pH control is therefore of great importance when selecting 
chromatographic conditions in reversed-phase chromatography as it 
controls the ratio of the relative concentrations of the protonated and 
unprotonated species and hence the distribution between the non-polar 
stationary phase and the polar mobile phase which in turn influences 
retention times [17-19]. Most reversed-phase chromatographic 
methods operate at pH values lying in the range between 2 and 8 [20].
Among the different types of buffers used in the mobile phases for 
HPLC, are phosphate buffers [21]. Phosphate buffers are widely used 
and favored due to their high purity, low cost and ease to produce good 
chromatograms. Such buffers also operate best at useful pH ranges. 
Phosphoric acid having three ionizable groups has three pKa values-2.1, 
7.2 and 12.3, respectively. When using these types of buffers, there are 3 
different buffering ranges. These lie in the regions of around pH 1.1-3.1, 
pH 6.2-8.2 and pH 11.3-13.3 [22].
The most commonly used organic modifiers in reversed-phase 
chromatography are acetonitrile and methanol. Although being 
more expensive, HPLC-grade acetonitrile has lower absorbance than 
HPLC- grade methanol at the wavelength of interest for detection. 
Furthermore, when mixed with water there is a lower increase in 
pressure when using acetonitrile. It is for this reason that acetonitrile 




Clindamycin phosphate and lincomycin hydrochloride standards were 
purchased from Sigma Aldrich (Steinheim, Germany). A 100 µg/mL 
solution of both clindamycin and lincomycin was prepared in HPLC-grade 
water (Fisher Chemical, Leicestershire, UK) and equal volumes of each 
were mixed together. These were stored until the time of analysis at 4°C in 
100 mL amber-colored volumetric flasks, to be protected from light.
Mobile phases
Mobile phases were prepared using a combination of acetonitrile (Fisher 
Chemical, Leicestershire, UK) and phosphate buffer. The buffer solution 
was prepared by dissolving anhydrous extra pure di- sodium hydrogen 
phosphate (Scharlau, Sentmenat, Spain) in HPLC-grade water to make 
up a solution of 0.02 M. The pH was adjusted by adding HPLC-grade 
orthophosphoric acid (Fisher Chemical, Leicestershire, UK) dropwise.
A total of nine different mobile phases were used (Table 1). The 
composition of the mobile phases consisted of a combination of pH 2.0, 3.0 
or 6.5 (higher pH values were not used due to the nature of the stationary 
phase) and a percentage acetonitrile composition of 20, 30 or 40%.
The particular pH values were selected for the analysis to ensure 
maximum buffering capacity, as it is best to use buffers within their 
Fig. 1: Lincomycin hydrochloride at a pH <7.6
Fig. 2: Clindamycin phosphate at a pH lower than 0.9
Fig. 3: Clindamycin phosphate at a pH value between 0.9 and 
6.081
Fig. 4: Clindamycin phosphate at a pH value above 6.081
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effective pH range by selecting a pH having a value of around ± 1 pH 
unit from the pKa of the buffer [24].
Instrumentation
Analysis was performed using an Agilent 1260 Infinity Series® liquid 
chromatographic system having a quaternary pump and multi-
wavelength detector. Separation took place on an ACE® RP C-18 column 
(250 mm × 4.6 mm; particle size 5 µm) at a temperature of 25°C. Mobile 
phase flow rate was of 1 mL/minute. The UV/visible detector was set 
at 205 nm. Sample volumes (containing clindamycin phosphate and 
lincomycin hydrochloride) of 25 µl were injected. To assist with peak 
identification solutions containing pure clindamycin phosphate and 
lincomycin hydrochloride respectively were injected. Five replicate 
injections using each type of the nine mobile phases were carried out to 
ensure reproducibility. Run time was adjusted for each chromatogram 
according to the type of mobile phase used. Averages for the retention 
time, areas under the peak and area percentages were calculated for 
each mobile phase used (Figs. 5-13).
All pH measurements were done using a Mettler Toledo FiveGo™ pH 
meter. Prior to taking every reading, the pH meter was calibrated using 
standard Hanna® calibrator buffer solutions (at pH values of 4.01 
and 7.01).
0LQXWHV          P$8  P$80:'6LJQDO$QP%ZQPOLQFRP\FLQ FOLQGDP\FLQ
Fig. 5: Disodiumhydrogen phosphate (pH 2.0) and acetonitrile 
(80:20 v/v)0LQXWHV       P$8  P$80:'6LJQDO$QP%ZQPOLQFRP\FLQFOLQGDP\FLQ
Fig. 6: Disodiumhydrogen phosphate (pH 2.0) and acetonitrile 
(70:30 v/v)0LQXWHV          P$8  P$80:'6LJQDO$QP%ZQP
Fig. 7: Disodiumhydrogen phosphate (pH 2.0) and acetonitrile 
(60:40 v/v)
0LQXWHV          P$8  P$80:'6LJQDO$QP%ZQPOLQFRP\FLQ FOLQGDP\FLQ
Fig. 8: Disodiumhydrogen phosphate (pH 3.0) and acetonitrile 
(80:20 v/v)     OLQFRP\FLQ FOLQGDP\FLQ P$8 P$80LQXWHV     0:'6LJQDO$QP%ZQP
Fig. 9: Disodiumhydrogen phosphate (pH 6.5) and acetonitrile 
(80:20 v/v)0LQXWHV       P$8  P$80:'6LJQDO$QP%ZQP
Fig. 10: Disodiumhydrogen phosphate (pH 6.5) and acetonitrile 
(70:30 v/v)
Table 1: Types of mobile phases used










Asian J Pharm Clin Res, Vol 7, Issue 5, 2014, 96-100
 Vella et al. 
99
RESULTS AND DISCUSSION
When observing chromatograms produced, it could be noted that peaks 
given by lincomycin were higher than those given for clindamycin. Both 
drugs were present in solution in the same concentration (100 µg/ml). 
The reason for this is due to lincomycin having a higher absorptivity than 
clindamycin phosphate at the wavelength selected for detection [25].
When using HPLC, working at high pH values can result in the 
solubilization of the silica support. This in turn damages the column 
and reduces its lifetime [26]. Since it is not advisable to conduct HPLC 
analysis at relatively alkaline pHs [27], lincomycin could only be mainly 
observed in its protonated form (at pH values lower than its pKa 
value). When analysis was conducted at pH values of 2.5 and 3.0, the 
first oxygen of the phosphate group of clindamycin was present in its 
unprotonated form (as the pH value was higher than the pKa1 value) 
whilst the second oxygen on the phosphate group was present in its 
protonated form (pH lower than pKa2). At a pH of 6.5 both oxygens of 
the phosphate group were unprotonated.
0LQXWHV          P$8  P$80:'6LJQDO$QP%ZQPOLQFRP\FLQFOLQGDP\FLQ
Fig. 11: Disodiumhydrogen phosphate (pH 3.0) and acetonitrile 
(70:30 v/v)0LQXWHV          P$8  P$80:'6LJQDO$QP%ZQP
Fig. 12: Disodiumhydrogen phosphate (pH 3.0) and acetonitrile 
(60:40 v/v)        OLQFRP\FLQFOLQGDP\FLQ P$8 P$80:'6LJQDO$QP%ZQP0LQXWHV
Fig. 13: Disodiumhydrogen phosphate (pH 6.5) and acetonitrile 
(60:40 v/v)
The higher the percentage of acetonitrile in the mobile phase, the 
shorter is the retention time [28]. At pH values of 2.0 and 3.0 there was 
a marked decrease in the retention time of clindamycin when more 
acetonitrile was used (Figs. 5-8). This shows that when the amount 
of solvent in the mobile phase is increased, there is less interaction of 
relatively polar compounds such as clindamycin with the stationary 
phase resulting in quicker elution probably due to a change in partition 
coefficient favouring more the mobile phase containing higher amounts 
of organic modifier.
At low pH values, the retention time of relatively less polar compounds 
such as lincomycin was unaffected. At a higher pH value of 6.5, however, 
increasing the acetonitrile percentage by 10% also affected the retention 
time of lincomycin with lincomycin eluting at a later time (Figs. 9 and 10).
At an increased composition of acetonitrile at pH 6.5, clindamycin 
eluted before lincomycin. This is because at pH 6.5 (which is above the 
two pKa values of clindamycin phosphate), clindamycin phosphate is 
present in its fully ionized form with both H’s of the phosphate group 
dissociated. This makes it relatively more polar, thus having less of an 
affinity for the stationary phase andeluting quicker. This is not observed 
in lower acetonitrile concentrations where lincomycin elutes first 
indicating that more acetonitrile would be needed to elute clindamycin 
before lincomycin at this pH.
Increasing the amount of acetonitrile produces sharper peaks 
(Figs. 6, 10 and 11).
Larger volumes of acetonitrile can also result in a decrease in resolution 
between two neighboring peaks. This could be clearly seen at pH values 
of 2.0 and 3.0 when the acetonitrile composition was adjusted to 40% 
(Figs. 7 and 12).
More than two peaks could be observed at one instance (Fig. 7) and 
the peaks produced were not symmetrical and were split. This is 
probably due to the reduced buffering capacity of the phosphate buffer 
at high organic modifier compositions. The use of a buffer having a 
stronger concentration would probably counteract such an occurrence, 
especially at lower pH values. When using 40% acetonitrile at pH 6.5 
better resolution of the two more symmetrical peaks was attained with 
less splitting when compared with the other pH values (Fig. 13).
CONCLUSION
This work shows how changing two important parameters such as 
pH of the buffer and percentage of acetonitrile in the mobile phase 
can affect separation and chromatographic results. In reversed- phase 
chromatography, buffer pH and amount of organic modifier in 
the mobile phase are two very important parameters that govern 
chromatographic results [29-33]. Effective and efficient separation of 
lincomycin hydrochloride and clindamycin phosphate can be achieved 
if the mobile phase is made up of the appropriate blend of polar and 
non- polar or less polar components as this modifies the distribution 
coefficient (Kd) for the partitioning of components between the 
stationary C18 phase and the mobile phase made up of acetonitrile and 
phosphate buffer.
The pH of the mobile phase is important when it comes to selectivity, 
efficiency and peak shape. The most appropriate pH must be chosen 
according to the type of buffer being used and also according to the 
compound’s pKa values. pH affects efficacy and efficiency of separation 
as it alters the relative amounts of non-ionized to ionized species in the 
mobile phase which in turn influences distribution of the non-ionized 
between the two phases.
For adequate retention and resolution, the amount of organic modifier 
in the mobile phase has to be adjusted simultaneously with the pH. 
To achieve adequate separation and resolution, buffer strength and 
concentration must be controlled in order to attain the maximum 
buffering capacity especially at high compositions of organic modifier.
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The amount of organic modifier must not be too low to avoid having 
retention times that are too long. However, it must not be increased 
to such an extent that the resolution between two or more peaks is 
decreased, and the buffering capacity altered.
The best separation of lincomycin hydrochloride and clindamycin 
phosphate with respect to retention times and areas of peaks was 
achieved when using a mobile phase of disodium hydrogen phosphate 
buffer and acetonitrile in the ratio of 70:30 (v/v) at a pH of 2 or 3.
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